Original ArticleInherent Tumor Characteristics That Limit Effective and Safe Resection of Giant Nonfunctioning Pituitary Adenomas
Introduction
Transsphenoidal surgery (TSS) has been the gold standard operative approach for nonfunctioning pituitary adenomas for decades. With the recent evolution of surgical techniques and instruments, including the endoscope, complete and safe resection is possible for many adenomas, and the ability to resect complex adenoma is evolving dramatically. However, several inherent tumor characteristics still limit effective and safe resection.1, 2, 3, 4, 5 Giant adenomas, usually defined as those with a maximum diameter >40 mm, may occasionally remain a therapeutic challenge because of their size, invasiveness, and irregular extrasellar extensions. Radical removal of giant adenomas has been achieved in fewer than one half of the cases described in the literature.2, 6, 7, 8, 9 Complex adenomas are not only difficult to resect but also have a greater risk of complications. Currently most pituitary surgeons favor endoscopic TSS in the surgical management of giant adenomas, although some tumors require an individualized surgical approach.6, 8, 10 Most giant adenomas are slow-growing and histologically benign tumors despite giant in size and troublesome to manage.11, 12, 13, 14 Here, we review the surgical outcome and histology of a large consecutive series of giant nonfunctioning adenomas to elucidate the factors that limit effective and safe resection. We also discuss current therapeutic strategies.
Section snippets
Patients
The cases of 128 consecutive patients with giant nonfunctioning adenoma, defined as tumors measuring ≥40 mm in their maximum diameter, surgically treated between 2008 and 2015 are reviewed herein. They made up 12.8% of the 1001 cases of surgical nonfunctioning adenoma managed during this period at our institute. The 71 men and 57 women ranged in age from 27 to 81 years (mean 48.1 years). Surgery was performed for the first time in 91 patients, whereas 37 patients (28.9%) had previously
Results
The maximum diameters and the intracranial extension index of the tumor ranged from 40.1 to 83.0 (48.1) mm and 0% to 90% (mean 41%), respectively. Marked CS invasion characterized 69 tumors (53.9%), irregular configuration 66 tumors (51.6%), and complete encasement of the subarachnoid arteries 13 tumors (10.2%). Tumor size correlated positively with marked CS invasion (P = 0.0005) and encasement of the subarachnoid arteries (P = 0.0047) but not with an irregular configuration. The intracranial
Histology of Giant Adenomas
Giant adenomas are mostly invasive and may be surgically challenging but most are slow growing, histologically benign, and gonadotrophic in their subtype.11, 12, 13, 14 The absence of a correlation between the MIB-1 index and tumor size has been demonstrated in several studies.11, 12, 13, 14, 17 In the present series, silent ACTH adenoma was diagnosed in 21.1% of the patients and Pit-1-lineage silent adenoma in 7.0%. Many authors have pointed out that the clinical features of these 2 uncommon
Conclusions
Endoscopic TSS, the extended approach, and the combined approach allowed total resection and subtotal resection apart from the CS of giant adenoma in 93 patients (72.7%). Most of the tumors were histologically benign, with a low MIB-1 index (<3.0%) beside a few tumors mainly silent adenomas of Pit-lineage. Irrespective of the surgical approach, massive intracranial extension, an irregular configuration, and marked CS invasion are inherent factors that independently limit effective resection.
References (28)
- et al.
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection
J Neurosurg
(2014) - et al.
Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations
J Neurosurg
(2013) - et al.
Simultaneous combined supra-infrasellar approach for giant/large multi-lobulated pituitary adenomas
World Neurosurg
(2011) - et al.
The current role of transcranial surgery in the management of pituitary adenomas
Pituitary
(2013) - et al.
Defining the “edge of the envelope”: patient selection in treating complex sellar-based neoplasms via transsphenoidal versus open craniotomy
J Neurosurg
(2011) - et al.
Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas
Clin Endocrinol
(2010) - et al.
Giant pituitary tumors: a study based on surgical treatment of 118 cases
Surg Neurol
(2004) - et al.
Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach
World Neurosurg
(2014) Recent evolution of endoscopic endonasal surgery for treatment of pituitary adenomas
Neurol Med Chir (Tokyo)
(2017)- et al.
Size does not matter. The intrigue of giant adenomas: a true surgical challenge
Acta Neurochir (Wien)
(2014)
Clinicopathological correlates of giant adenomas
J Clin Neurosci
Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling
Am J Surg Pathol
The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas
Endocr Pathol
Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas
Endocr Pathol
Cited by (32)
Simultaneous combined endoscopic endonasal and transcranial surgery for giant pituitary adenomas: Tips and traps in operative indication and procedure
2022, Clinical Neurology and NeurosurgeryCitation Excerpt :Even now, when substantial advances in endoscopic endonasal surgery have been achieved, giant pituitary adenomas remain challenging to treat [1–6].
Giant Pituitary Adenoma – Special Considerations
2022, Otolaryngologic Clinics of North AmericaCitation Excerpt :Nevertheless, it is important to note that the combined approach is logistically challenging and requires 2 surgical teams, operative fields, sets of operating instruments, and potentially operating microscopes.128 Eight case series encompassing 96 GPA patients have been published on using a combined surgical approach for GPA resection (Table 4).7,22,34,84,120,126,127,129 These case series have combined a TC procedure with the MT approach,7,120 the EET approach,22,84,126,129 or both transsphenoidal modalities.34,127
Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.